Skip to main content

Search This Blog

Prostate Cancer

Posts

Can frequent UTIs be a sign of bladder cancer?

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 06, 2026

Invalid Access Key! Invalid Access Key!

Hepatitis C and liver cancer: What to know

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 06, 2026

Invalid Access Key! Invalid Access Key!

PET scans: What are they and what to expect

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 06, 2026

Invalid Access Key! Invalid Access Key!

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 06, 2026

Invalid Access Key! Invalid Access Key!

Diagnosing Cancer: Screening Labs, Tests, Biopsies & More

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 05, 2026

Invalid Access Key! Invalid Access Key!

Drug repurposing for cancer therapy

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 05, 2026

Invalid Access Key! Invalid Access Key!

Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 05, 2026

Invalid Access Key! Invalid Access Key!

Powered by Blogger

Theme images by billnoll

Popular Posts

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer - Technology Networks

- July 03, 2020

Drugs that can ‘reprogramme’ immune cells from protecting cancer to attacking it could be an effective new treatment for some men with advanced prostate cancer, a new study shows. Researchers found that immune cells called macrophages, already drawn into prostate cancer tumours to help promote growth, can be targeted and rewired to attack the disease. In studies of cancer cells and mice with prostate cancer a so-called CXCR2 inhibitor, which blocks a protein receptor on macrophages, inhibited tumour growth by switching them from helping the tumour to triggering anti-tumour immune responses instead. The drug, called AZD5069, is now being studied in a clinical trial led by researchers at The Institute of Cancer Research and our partner hospital The Royal Marsden NHS Foundation Trust, to test its effectiveness in men with advanced prostate cancer. The new research, published in the journal published in the journal Cell Reports , was carried out by a Eur...

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

- December 24, 2024

warning signs of colon cancer :: Article Creator I'm A 34-year-old With Colon Cancer And I Don't Know How Long I Have Left - I Kick Myself For Ignoring Two Key Warning Signs By JONATHAN NEAL FOR MAILONLINE Published: 06:42 EST, 9 December 2024Updated: 16:55 EST, 11 December 2024 A 34-year-old man diagnosed with incurable colon cancer has revealed the key symptoms he dismissed — in a bid to help others avoid the same fate. Joe Faratzis first began suffering problems in 2019, including 'a dull, mild ache' in the lower right of his abdomen from time to time that 'was easy to ignore and forget about'. He visited his doctor who asked about his bowel habits and referred him for scans but, heartbreakingly, Mr Faratzis didn't go through with the tests, admitting: 'I assumed it was unnecessary.' Six months later he began noticing blood on the toilet paper when he went to the bathroom, but again claims he 'wasn...

Bayer, Orion prep challenge in prostate cancer market - PMLiVE

- February 18, 2019

Bayer and Orion have put some meat on the bones of their phase 3 trial of darolutamide in non-metastatic castration-resistant prostate cancer (CRPC), as they prepare to take on rival therapies from Johnson & Johnson and Pfizer/Astellas. The two partners released top-line results from the ARAMIS trial of darolutamide last year, but have now presented the data in full at the ASCO Genitourinary (GU) symposium and published the study in the New England Journal of Medicine . The verdict of the 1,509-patient trial is that darolutamide added to androgen deprivation therapy (ADT) achieved a 59% reduction in the risk of metastasis or death versus ADT plus placebo, with a median metastasis-free survival of 40.4 months compared to 18.4 months, respectively. There was also a trend towards an increase in overall survival of 29% versus placebo, and patients will be monitored in the coming months to see if this develops into a statistically significant improvement. Bayer and Orion say they...

After Beating Cancer Twice, Larry King, 87, Has Died– Legendary Talk Show Host Had Incredible Staying Power - SurvivorNet

- August 18, 2021

Larry King, Hospitalized With COVID-19, Is a Warrior Larry King Live talk show host Larry King, 87, is currently in the hospital fighting COVID-19; he reportedly left the ICU on Sunday. King survived lung cancer in 2017 and prostate cancer in 1999; he has also suffered a stroke and heart disease in the past. For people battling cancer during the COVID-19 pandemic, it's especially important to exercise safety precautions, due to some cancer treatments leading to an immunocompromised state. Legendary TV host and broadcast journalist, Larry King, 87, has spoken of his "indomitable spirit" which allowed him to overcome multiple health issues, including lung cancer in 2017; now, King has passed away from cancer after a battle with COVID. He had previously been treated at Cedars Sinai Medical Center in Los Angeles. And due to safety protocols, it's being reported by CNN that his three sons are not able to visit him in the hospital. Related: A Message on World Lung Cancer D...

Genotype linked to shorter survival in metastatic prostate cancer - Urology Times

- March 02, 2020

Inheriting the adrenal-permissive HSD3B1(1245C) genotype is associated with worse outcomes in low-volume metastatic prostate cancer and might someday help identify patients who could benefit from escalated therapy, according to a recent study. In essence, some patients are genetically predisposed to having their prostate cancers make their own potent androgens, such as testosterone or dihydrotestosterone (DHT), from non-testicular sources, according to study author Nima Sharifi, MD, of Cleveland Clinic Genitourinary Malignancies Research Center, Cleveland. “This comes from germline inheritance of an effectively ‘fast’ enzyme by the gene HSD3B1 that allows for prostate cancer to make these androgens. What this means clinically is that men with low-volume metastatic prostate cancer who inherit this fast form of HSD3B1 treated with medical or surgical castration progress more quickly and have shorter survival compared with men who do not inherit this fast enzyme,” Dr. Sharifi said. Re...

Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6⁻7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8⁻10. - UroToday

- April 07, 2019

Gleason score (GS) 8⁻10 is associated with adverse outcomes in prostate cancer (PCa). However, biopsy GS (bGS) may be upgraded or downgraded post-radical prostatectomy (RP). We aimed to investigate predictive factors and oncologic outcomes of downgrade to pathologic GS (pGS) 6⁻7 after RP in PCa patients with bGSs 8⁻10. We retrospectively reviewed clinical data of patients with bGS ≥ 8 undergoing RP. pGS downgrade was defined as a pGS ≤ 7 from bGS ≥ 8 post-RP. Univariate and multivariate cox regression analysis, logistic regression analysis, and Kaplan⁻Meier curves were used to analyze pGS downgrade and biochemical recurrence (BCR). Of 860 patients, 623 and 237 had bGS 8 and bGS ≥ 9, respectively. Post-RP, 332 patients were downgraded to pGS ≤ 7; of these, 284 and 48 had bGS 8 and bGS ≥ 9, respectively. Prostate-specific antigen (PSA) levels; clinical stage; and adverse pathologic features such as extracapsular extension, seminal vesicle invasion and positive surgical margin were signif...

Finding clarity in confusion about prostate cancer screening - AdVantageNEWS.com

- June 23, 2019

Dr. Andy Peterson, a family physician at OSF Medical Group in Kewanee, often sees men make an appointment with him after a heart attack or a cancer scare. Men are notoriously bad about getting regular check-ups, but that could be changing. The latest data from the Centers for Disease Control and Prevention show 64 percent of men said they’d seen a doctor in the past six months. June is Men’s Health Month, designed to raise awareness about the need to get regular preventative screenings and check-ups. One of the more challenging messages involves prostate cancer screening. Recommendations have changed several times in the past decade, including as recently as a year ago. Dr. Eminajulo (Emi) Adekoya, a urologist with OSF HealthCare Medical Group in Alton, says the U.S. Preventative Services Task Force latest recommendations suggest a PSA blood test can reduce the chance of death from prostate cancer in some men but it can also lead to false positives, overtreatment and serious side e...

Minimally invasive treatment option for enlarged prostate - PAHomePage.com

- February 28, 2019

Iowa News Anchor Showered With Support After Revealing Breast ...

- June 27, 2023

prostate screening :: Article Creator Prostate Cancer Screening And The Golden Rule Of Humanity Takeshi Takahashi, public health physician, former urological surgeon Health and Welfare Bureau, Kitakyushu city office, Jyonai 1-1, Kitakyushu 803-8501, Japan jazzy{at}kuhp.Kyoto-u.Ac.Jp The discussion around prostate cancer screening continues.1 I worked as a urologist for 30 years. When I was young, I hoped only to become an independent urologist and to gain as much surgical experience as possible. But as I approached the target age for prostate specific antigen (PSA) screening, and having heard the opinions of public health experts,23 I could no longer recommend PSA … Senior Living: How To Treat, Prevent Prostate Issues, Including Cancer By Dr. Jennifer Liu, Guest columnist Prostate health is an important issue in aging men. Major health complications can arise from prostate issues, including prostate cancer, decreased quality...

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

- February 13, 2025

signs of gallbladder cancer :: Article Creator 7 Signs You Have Pancreatic Cancer Pancreatic cancer is one of the most challenging cancers to diagnose early because it rarely causes symptoms in its initial stages. By the time symptoms appear, the disease has often advanced significantly, making early detection difficult. However, understanding the warning signs can help individuals seek medical attention sooner, potentially improving outcomes. Fatigue and Physical Weakness Many individuals with pancreatic cancer experience unexplained fatigue and physical weakness, often unrelated to physical exertion. This persistent lack of energy may also be accompanied by difficulty sleeping and feelings of depression. While fatigue is a common symptom of various conditions, its presence alongside other pancreatic cancer symptoms may warrant further investigation. Jaundice and Related Symptoms Jaundice, a condition characterized by yellowing of the...

Archive

November 202612
October 202632
September 202634
August 202650
July 202656
June 202644
May 202631
April 202658
March 2026111
February 202677

Show more Show less

Labels

"cancer prostata" - Google News
"metastatic prostate cancer" - Google News
"prostate cancer causes" - Google News
"prostate cancer survival rate" - Google News
"prostate cancer treatment options" - Google News
"prostate cancer treatment" - Google News
"prostate cancer" - Google News
"prostatectomy" - Google News
"symptoms of prostate cancer in men" - Google News
cancer+prostata - Google News

Google News
IFTTT
metastatic prostate cancer
metastatic+prostate+cancer - Google News
prostate cancer
prostate cancer causes
prostate cancer survival rate
prostate cancer treatment
prostate cancer treatment options
prostate+cancer - Google News
prostate+cancer+causes - Google News
prostate+cancer+survival+rate - Google News
prostate+cancer+treatment - Google News
prostate+cancer+treatment+options - Google News
prostatectomy
prostatectomy - Google News
symptoms of prostate cancer in men
symptoms+of+prostate+cancer+in+men - Google News

Show more Show less